Le Pen’s budget plan avoids pension reform; after the Franco-German yield spread surpasses 150 basis points, the 200 basis point warning is triggered.
France's fiscal pressures continue to intensify, and whether pension reform can be relaunched will be crucial in determining the direction of France's borrowing costs and bond market stress.
On October 8, Reuters reported that Mike Bell, Market Strategist at RBC BlueBay Asset Management, stated that the market is closely monitoring the main candidates for France's 2027 presidential election, especially the far-right candidate Le Pen, who is leading in the polls, to see if she will pledge to raise the retirement age. If the main candidates are inclined to maintain the current retirement age, the yield spread between French and German 10-year government bonds could further widen to 200 basis points.
Le Pen unveiled part of her fiscal plan this Tuesday, but did not mention pension reform, only saying she would announce more policy details in the coming weeks. Previously, she advocated lowering the retirement age to 60 for early entrants to the workforce. Bell believes the market wants to see the most likely winners make a clear commitment to raising the retirement age; otherwise, pressure on France's bond market may continue to build.
Pressure on the French bond market has already heated up noticeably. Last Friday, the yield spread between French and German 10-year government bonds breached 150 basis points, marking a new high since the end of 2011. Bell said that with several months remaining until the election, it takes "considerable courage" to increase holdings of French government bonds at current levels; at the same time, French bonds have already priced in a higher risk premium, so the risk of continuing to go short is also rising.
High Pension Spending, Reform Faces Political Resistance
Pensions make up France's largest single fiscal expenditure, expected to reach €436 billion next year, accounting for 14% of GDP. France's retirement age is relatively low, while residents' life expectancy is longer, making pension spending a long-term key source of fiscal pressure.
France's reform launched in 2023 originally planned to gradually raise the retirement age from 62 to 64, but the reform was suspended last year during budget negotiations. Previously, Le Pen advocated lowering the retirement age to 60 for early entrants. Since elderly voters are a major support group for her National Rally leadership, pension reform is highly sensitive politically for Le Pen.
If the main candidates in the future cannot clearly commit to raising the retirement age, the market may keep demanding a higher risk premium for French government bonds, and the Franco-German yield spread may widen further.
Both Long and Short Positions on French Bonds Require Caution, European Central Bank Support Has Barriers
RBC BlueBay, with assets under management of $598 billion, currently still holds some French government bonds, but Bell said the company is deliberately maintaining an underweight position and will not actively increase holdings prior to the election outcome becoming clear. At the same time, he does not favor continuing aggressive short positions, as French bonds already reflect a significant portion of fiscal and political risk.
Bell also pointed out the limitations of European Central Bank policy support. The European Central Bank’s Transmission Protection Instrument (TPI) requires member countries to comply with EU fiscal rules, but France currently does not meet these conditions. This means that if France's bond market comes under further pressure due to fiscal or political risks, the ECB’s room for providing policy support may be limited.
If Le Pen is ultimately elected, fiscal policy differences between the French government, the EU, and the European Central Bank could become more pronounced. Bell believes that elevated French government bond yields may even become a source of pressure for the next government to strengthen fiscal discipline.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
CleanTech Lithium expands foothold in Argentina
BUZZ-Better Home & Finance shares rise after announcing a $30 million stock buyback plan
October 8 - Better Home & Finance (BETR.O), a mortgage and home equity financing company, saw its stock price rise 3.8% to $10.30 in pre-market trading after announcing a share repurchase plan. BETR stated that its board of directors has approved a stock buyback program of up to $30 million, with an initial phase of $10 million to kick off the repurchase. The company plans to adjust the pace of the repurchase based on realized operational cost savings and asset disposal progress, such as the proposed sale of its UK bank subsidiary. The buyback program is set to expire on October 8, 2027. In August, BETR forecasted that its Q3 revenue would be below Wall Street expectations as it focuses on partnership opportunities and accelerating the development of its home equity credit business. As of the previous trading day's close, the company's market capitalization was approximately $175 million. As of Wednesday, the stock has dropped about 70% year-to-date. According to LSEG data, seven out of eight analysts rate the stock as "strong buy" or "buy," with one rating it as "hold"; the median target price is $25. (For the convenience of non-English speakers, Reuters provides translated automated reports in several other languages. As automated translations may contain errors or lack required context, Reuters does not guarantee the accuracy of these texts and provides them simply for convenience. Reuters accepts no liability for any damage or loss arising from the use of automated translation.)
Fed Governor Waller leaves room for hawkishness: More rate hikes are needed to support inflation decline, not necessarily on a monthly basis.
Federal Reserve Governor Waller stated that if the data meets expectations, there will be further interest rate hikes. The core PCE year-on-year rate at 3% is still too high, and the recent monetary policy focus remains on fighting inflation.
Updated: Viatris will acquire pain therapy manufacturer Pacira BioSciences for 1.65 billions dollars.
The second paragraph adds stock information, while the fifth, eighth, and ninth paragraphs provide additional details. Background information is supplemented in the sixth, seventh, tenth, and eleventh paragraphs. Reuters, October 8 – Pharmaceutical company Viatris (VTRS.O) will acquire Pacira BioSciences (PCRX.O) in an all-cash deal worth $1.65 billions, adding two non-opioid painkillers to its portfolio, the companies said on Thursday. Viatris will acquire Pacira at $36.50 per share, representing a 44.8% premium to the latest closing price. Pacira’s stock rose by 44% in premarket trading. Pacira’s non-opioid painkillers, Exparel and Zilretta, generated sales in 2025 of $575.1 millions and $116.6 millions respectively. Exparel is used to relieve acute pain after surgery, and Zilretta is used to treat pain associated with knee osteoarthritis. Viatris stated it expects to expand the reach of these products in selected target markets. Viatris CEO Scott Smith stated, “the addition of these medications creates a synergy with our rapid-acting meloxicam market opportunities, positioning us as a leader in non-opioid pain management.” The US Food and Drug Administration (FDA) is expected to make a decision by December 27 on the approval application for rapid-acting meloxicam for the treatment of moderate to severe acute pain. Viatris plans to finance the acquisition primarily with idle cash, and the remainder through short-term borrowing. The company noted the deal will have minimal impact on its total leverage ratio. In August, Viatris (link) raised its annual adjusted profit forecast, counting on strong brand drug sales and growth in the Chinese market. The pharmaceutical company had previously faced (link) production setbacks in its Indian operations, including a fire at its Nashik plant in western India and increased competition in the generic drug market, raising concerns about the resilience and growth of its core business. The company stated the transaction is expected to close by the end of 2026 and will immediately enhance Viatris’s financial guidance metrics. (For non-native English speakers, Reuters provides automated translations of its reports into several other languages. Since automated translations may contain errors or lack necessary context, Reuters does not guarantee their accuracy and provides them for convenience only. Reuters accepts no liability for any damage or loss caused by the use of automated translation.)
Crypto prices
More
